Traditional Chinese medicine composition for promoting construction of coronary collateral circulation
A technology of coronary arteries and compositions, applied in the field of traditional Chinese medicine compositions that promote the establishment of coronary artery collateral circulation, can solve problems such as liver function damage, achieve the goal of alleviating arteriosclerosis, promoting the establishment of coronary artery collateral circulation, and promoting revascularization Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038]Proportions (parts by weight): 10 ginseng, 30 astragalus, 15 fleece-flower root, 10 dogwood, 10 pangolin, 2 leeches, 15 peony bark, 15 red peony, 15 zedoary, 30 gynostemma, 30 radishes, 15 schisandra, 15 dodder, atractylodes 10, Poria cocos 20, ginkgo biloba 15, epimedium 15, brown sugar 8.
[0039] Preparation:
[0040] (1) Grind the leeches into 80 mesh powders for subsequent use;
[0041] (2) Add ginseng, astragalus, Polygonum multiflorum, Cornus officinalis, Ginkgo biloba (single gauze bag) and Epimedium into 75% ethanol and extract once at 50-60°C (the amount of 75% ethanol is the total amount of the above six raw materials). 1.5 times of mass), leaching time 5 hours; then add 60% ethanol 50~60 ℃ and extract 1 time (the consumption of 60% ethanol is 1.2 times of the total mass of crude drug), leaching time 3 hours; The extract is finely filtered through a 200-mesh sieve, concentrated, dried to a moisture content of ≤10%, and then crushed to a particle size of 300-...
Embodiment 2
[0044] The clinical experiment of embodiment 2 Chinese medicine composition of the present invention
[0045] 1. Inclusion criteria
[0046] From June 2014 to June 2015, 100 patients with coronary heart disease angina pectoris and / or coronary heart disease myocardial infarction were admitted to the hospital, including 62 males and 38 females, aged 38-75 years. 100 patients were randomly divided into treatment group and control group, 50 cases each. Coronary angiography showed that 2 or more than 2 coronary arteries were narrowed or occluded by more than 75%, and all cases had complete and detailed medical history, electrocardiogram, laboratory examination and other clinical data. Exclusion criteria: patients with diabetes mellitus, severe cardiac insufficiency, malignant lesions, patients undergoing coronary artery bypass grafting, etc. who are not suitable for clinical observation of treatment effects.
[0047] 2. Treatment
[0048] Control group: basic treatments such as ...
Embodiment 3
[0061] Typical case of embodiment 3 Chinese medicine composition of the present invention
[0062] Case 1: Ma XX, male, 45 years old. She suffered from paroxysmal chest pain for 2 years and denied any history of hypertension or diabetes. The patient experienced precordial discomfort, dull pain, and fatigue during heavy physical activity, which lasted for about 10 minutes each time and relieved after rest. Half a year ago, there was an attack without obvious incentives, with dull pain in the precordial area, which lasted for about 5 minutes but accompanied by dizziness and amaurosis. Coronary angiography showed multiple lesions in multiple vessels, including 80% stenosis in the middle of the anterior descending branch; the proximal circumflex branch, The middle segment stenosis was 40% and 85% respectively; the proximal, middle and distal segments of the right coronary artery were 95%, 65% and 90% stenosis respectively. Diagnosed as coronary heart disease, exertional angina p...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com